EDTA improves stability of whole blood C-peptide and insulin to over 24 hours at room temperature

Timothy J McDonald, Mandy H Perry, Roy W A Peake, Nicola J Pullan, John O'Connor, Beverley M Shields, Beatrice A Knight, Andrew T Hattersley, Timothy J McDonald, Mandy H Perry, Roy W A Peake, Nicola J Pullan, John O'Connor, Beverley M Shields, Beatrice A Knight, Andrew T Hattersley

Abstract

Introduction: C-peptide and insulin measurements in blood provide useful information regarding endogenous insulin secretion. Conflicting evidence on sample stability and handling procedures continue to limit the widespread clinical use of these tests. We assessed the factors that altered the stability of insulin and C-peptide in blood.

Methods: We investigated the impact of preservative type, time to centrifugation, storage conditions and duration of storage on the stability of C-peptide and insulin on three different analytical platforms.

Results: C-peptide was stable for at least 24 hours at room temperature in both centrifuged and whole blood collected in K(+)-EDTA and serum gel tubes, with the exception of whole blood serum gel, which decreased to 78% of baseline at 24 hours, (p = 0.008). Insulin was stable at room temperature for 24 hours in both centrifuged and whole blood collected in K(+)-EDTA tubes. In contrast insulin levels decreased in serum gel tubes both centrifuged and whole blood (66% of baseline, p = 0.01 and 76% of baseline p = 0.01, by 24 hours respectively). C-peptide and insulin remained stable after 6 freeze-thaw cycles.

Conclusions: The stability of C-peptide and insulin in whole blood K(+)-EDTA tubes negates the need to conform to strict sample handling procedures for these assays, greatly increasing their clinical utility.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Flow diagram detailing the sample…
Figure 1. Flow diagram detailing the sample collection protocol for the preservative and stability study over 24 hours.
At each time point the samples were centrifuged at 3000g for 10 minutes and the supernatant frozen at −80°C.
Figure 2. Stability of C-peptide and insulin…
Figure 2. Stability of C-peptide and insulin in plasma and serum at room temperature and 4°C.
Blood taken from 3 non-diabetic volunteers assayed on the E170, Centaur and Immulite 2000 platforms. The samples were stored at room temperature (top row; figures A and B) and in the fridge at 4°C (bottom row; figures C and D) at 0.5, 1.0, 2.0, 6.0, 12 and 24 hours before freezing at −80°C. Data presented as mean percentage of baseline at each time point, with error bars representing the 95% confidence intervals. Red lines indicates samples collected K+-EDTA, blue lines indicate blood collected into serum gel, solid lines indicate whole blood and dashed lines indicate sample centrifuge at baseline.
Figure 3. Five day stability of C-peptide…
Figure 3. Five day stability of C-peptide and insulin in whole blood stored on K+-EDTA and serum gel at room temperature and 4°C.
Blood taken from 5 non-diabetic volunteers assayed on the E170. The samples were stored at room temperature (top row; figures A and B) and in the fridge at 4°C (bottom row; figures C and D) at 0, 12, 24, 36, 48, 72, 96 and 120 hours before freezing at −80°C. Data presented as mean percentage of baseline at each time point, with error bars representing the 95% confidence intervals. Red lines indicate samples collected in K+-EDTA, blue lines indicate blood collected into serum gel.

References

    1. Saddig C, Bender R, Starke AA (2002) A new classification plot for the C-peptide suppression test. JOP 3: 16–25.
    1. Jermendy G (1996) Hypoglycemia factitia: Munchhausen syndrome in diabetes mellitus. J Diabetes Complications 10: 223–225.
    1. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, et al. (1981) Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210: 153–156.
    1. Koskinen PJ, Viikari JS, Irjala KM (1988) Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity. Diabetes Care 11: 318–322.
    1. Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, et al. (1996) Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Diabetes Metab 22: 185–191.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.
    1. Assay Finder website. Available: . Accessed 2011 Jul 28.
    1. Kubasik NP, Ricotta M, Hunter T, Sine HE (1982) Effect of duration and temperature of storage on serum analyte stability: examination of 14 selected radioimmunoassay procedures. Clin Chem 28: 164–165.
    1. Evans MJ, Livesey JH, Ellis MJ, Yandle TG (2001) Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem 34: 107–112.
    1. Livesey JH, Hodgkinson SC, Roud HR, Donald RA (1980) Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 13: 151–155.
    1. Jane Ellis M, Livesey JH, Evans MJ (2003) Hormone stability in human whole blood. Clin Biochem 36: 109–112.
    1. Lindsay RS, Walker JD, Halsall I, Hales CN, Calder AA, et al. (2003) Insulin and Insulin Propeptides at Birth in Offspring of Diabetic Mothers. Journal of Clinical Endocrinology & Metabolism 88: 1664–1671.
    1. Walters E, Henley R, Barnes I (1986) Stability of insulin in normal whole blood. Clin Chem 32: 224.
    1. Smith S, Tolliday U, Shakespear R, Hartland A, Clark P (1996) Stability of samples for insulin, proinsulin and C-peptide. Journal of Endocrinology 151: P20.
    1. Bolner A, Lomeo L, Lomeo AM (2005) “Method-specific” stability of serum C-peptide in a multicenter clinical study. Clin Lab 51: 153–155.
    1. Bristow AF, Das RE (1988) WHO international reference reagents for human proinsulin and human insulin C-peptide. J Biol Stand 16: 179–186.
    1. Wiedmeyer HM, Polonsky KS, Myers GL, Little RR, Greenbaum CJ, et al. (2007) International comparison of C-peptide measurements. Clin Chem 53: 784–787.
    1. Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, et al. (2008) Standardization of C-peptide measurements. Clin Chem 54: 1023–1026.
    1. Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, et al. (2007) Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 53: 711–716.
    1. Van Uytfanghe K, Thienpont LM (2010) Standardization of insulin and C-peptide - A status report. Médecine Nucléaire 34: 566–570.
    1. Miller WG, Thienpont LM, Van Uytfanghe K, Clark PM, Lindstedt P, et al. (2009) Toward standardization of insulin immunoassays. Clin Chem 55: 1011–1018.

Source: PubMed

3
Subscribe